Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients

被引:215
作者
Chowbay, B
Cumaraswamy, S
Cheung, YB
Zhou, QY
Lee, EJD
机构
[1] Natl Canc Ctr, Div Clin Trials & Epidemiol Sci, Lab Clin Pharmacol, Singapore 169610, Singapore
[2] Natl Heart Ctr, Dept Cardiothorac Surg, Singapore, Singapore
[3] Natl Canc Ctr, Div Clin Trials & Epidemiol Sci, Biostat Unit, Singapore, Singapore
[4] Natl Univ Singapore, Fac Med, Dept Pharmacol, Singapore 117548, Singapore
来源
PHARMACOGENETICS | 2003年 / 13卷 / 02期
关键词
MDR1; CYP3A4; Asian population; P-glycoprotein; ethnicity; cyclosporine A; pharmacokinetics;
D O I
10.1097/00008571-200302000-00005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Intestinal cytochrome P-450 3A4 (CYP3A4) and P-glycoprotein (P-gp) both play a vital role in the metabolism of oral cyclosporine (CsA). We investigated the genetic polymorphisms in CYP3A4 (promoter region and exons 5, 7 and 9) and MDR1 (exons 12, 21 and 26) genes and the impact of these polymorphisms on the pharmacokinetics; of oral CsA in stable heart transplant patients (n = 14). CYP3A4 polymorphisms were rare in the Asian population and transplant patients. Haplotype analysis revealed 12 haplotypes in the Chinese, eight in the Malays and 10 in the Indians. T-T-T was the most common haplotype in all ethnic groups. The frequency of the homozygous mutant genotype at all three loci (TT-TT-TT) was highest in the Indians (31%) compared to 19% and 15% in the Chinese and Malays, respectively. In heart transplant patients, CsA exposure (AUC(0-4) (h), AUC(0-12) (h) and C-max) was high in patients with the T-T-T haplotypes compared to those with C-G-C haplotypes. These findings suggest that haplotypes rather than genotypes influence CsA disposition in transplant patients.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 22 条
[1]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[2]   MDR1 pharmacogenetics:: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity [J].
Ameyaw, MM ;
Regateiro, F ;
Li, T ;
Liu, XH ;
Tariq, M ;
Mobarek, A ;
Thornton, N ;
Folayan, GO ;
Githang'a, J ;
Indalo, A ;
Ofori-Adjei, D ;
Price-Evans, DA ;
McLeod, HL .
PHARMACOGENETICS, 2001, 11 (03) :217-221
[3]   Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4 [J].
Ball, SE ;
Scatina, JA ;
Kao, J ;
Ferron, GM ;
Fruncillo, R ;
Mayer, P ;
Weinryb, I ;
Guida, M ;
Hopkins, PJ ;
Warner, N ;
Hall, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (03) :288-294
[4]   Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects [J].
Cascorbi, I ;
Gerloff, T ;
Johne, A ;
Meisel, C ;
Hoffmeyer, S ;
Schwab, M ;
Schaeffeler, E ;
Eichelbaum, M ;
Brinkmann, U ;
Roots, I .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :169-174
[5]   INTERNAL DUPLICATION AND HOMOLOGY WITH BACTERIAL TRANSPORT PROTEINS IN THE MDR1 (P-GLYCOPROTEIN) GENE FROM MULTIDRUG-RESISTANT HUMAN-CELLS [J].
CHEN, CJ ;
CHIN, JE ;
UEDA, K ;
CLARK, DP ;
PASTAN, I ;
GOTTESMAN, MM ;
RONINSON, IB .
CELL, 1986, 47 (03) :381-389
[6]   C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation [J].
Goto, M ;
Masuda, S ;
Saito, H ;
Uemoto, S ;
Kiuchi, T ;
Tanaka, K ;
Inui, K .
PHARMACOGENETICS, 2002, 12 (06) :451-457
[7]   Functional polymorphisms of the human multidrug-resistance gene:: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J].
Hoffmeyer, S ;
Burk, O ;
von Richter, O ;
Arnold, HP ;
Brockmöller, J ;
Johne, A ;
Cascorbi, I ;
Gerloff, T ;
Roots, I ;
Eichelbaum, M ;
Brinkmann, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3473-3478
[8]  
Hsieh KP, 2001, DRUG METAB DISPOS, V29, P268
[9]   Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects [J].
Ito, S ;
Ieiri, I ;
Tanabe, M ;
Suzuki, A ;
Higuchi, S ;
Otsubo, K .
PHARMACOGENETICS, 2001, 11 (02) :175-184
[10]   The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors [J].
Kim, RB ;
Fromm, MF ;
Wandel, C ;
Leake, B ;
Wood, AJJ ;
Roden, DM ;
Wilkinson, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :289-294